Markus Schlaich (Australia) answers the following questions:
- Can you tell us more about the RHC "fil rouge" patients presented in Berlin, and the objectives of using these patients?
- Please tell us more about your preferred therapy for the elderly patient, the metabolic patient and the young adrenergic patient
- What was your favorite session at RHC 2014 and why?
To leave a comment, please create your free account here !